Results 121 to 130 of about 92,398 (247)
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Qian Zhang +99 more
openalex +1 more source
Objective Peripheral blood leukocyte telomere length (PBL‐TL) shortening is associated with systemic sclerosis–related interstitial lung disease (SSc‐ILD). However, its association with other organ involvement, disease severity, and survival remains unclear.
Monica M. Yang +6 more
wiley +1 more source
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley +1 more source
IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus [PDF]
Thomas Winkler +2 more
openalex +1 more source
Autoantibodies to the platelet-derived growth factor receptor in systemic sclerosis [PDF]
Mariusz Puszczewicz +1 more
openalex
shRNA-Targeting Caspase-3 Inhibits Cell Detachment Induced by Pemphigus Vulgaris Autoantibodies in HaCaT Cells [PDF]
Deyanira Pacheco‐Tovar +8 more
openalex +1 more source
Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis [PDF]
Minna Koivula +5 more
openalex +1 more source
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo +15 more
wiley +1 more source
Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis [PDF]
Osamu Higuchi +3 more
openalex +1 more source

